Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

How Eli Lilly Allegedly Used a Fake Rule and Fake News to Protect Bad Patents

Although the dust may have settled from a Canadian lawsuit Eli Lilly lost over patents for two of its drugs, Zyprexa and Strattera, questions remain over the manner in which the Indianapolis-based company fought in court.

Read More »

Bristol-Myers Kidney Cancer Drug Flunks Study

Bristol-Myers Squibb released mixed top-line results from its Phase III CheckMate-214 clinical trial of Opdivo in combination with Yervoy for advanced or metastatic RCC.

Read More »

W2O Group’s Sentient Adds Dominic Viola and Michael Spitz To Leadership Team

W2O Sentient announced the appointment of respected industry leaders Dominic Viola as Managing Director, Client Services, and Michael Spitz as Practice Leader, Strategy.

Read More »

End of U.S. payments to health insurers would cause premiums to rise: CBO

Health insurance premiums for many customers on the Obamacare individual insurance markets would be 20 percent higher in 2018 if U.S. President Donald Trump follows through on a threat to stop billions of dollars of payments to health insurers, a nonpartisan congressional office said.

Read More »

Flimsy evidence behind many FDA approvals

Many drugs granted accelerated approval and most high-risk medical devices approved by FDA lack clear evidence of safety and effectiveness, per JAMA reports.

Read More »

Centene to sell Obamacare plans in Nevada during 2018

Centene Corp., one of the largest players in the Obamacare individual insurance market, said it would offer Obamacare plans in Nevada in 2018.

Read More »

Lack of sleep tied to higher risk of diabetes in kids

Children who do not get enough sleep may be more likely to develop diabetes than kids who typically get enough shuteye, a UK study suggests.

Read More »

South Carolina sues OxyContin maker Purdue

South Carolina sued Purdue Pharma, accusing the OxyContin maker of deceptive marketing practices that have contributed to a national opioid addiction epidemic.

Read More »

Discovery Worldwide Names Stephanie Franke as VP, Creative Director

Discovery Worldwide announced the appointment of Stephanie Franke as VP, Creative Director. Franke reports directly to TJ Cimfel, Group VP Creative Director.

Read More »

Takeda Forges Alliance with Stanford University

Takeda Pharmaceutical announced a collaboration to help transform novel Stanford University research into next-generation treatments for diseases.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!


Ad Right Bottom